BLACKSTONE INC (BX)
US09260D1072 - Common Stock
We assign a fundamental rating of 4 out of 10 to BX. BX was compared to 218 industry peers in the Capital Markets industry. BX has a medium profitability rating, but doesn't score so well on its financial health evaluation. While showing a medium growth rate, BX is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year BX was profitable.
In the past year BX had a positive cash flow from operations.
Each year in the past 5 years BX has been profitable.
Each year in the past 5 years BX had a positive operating cash flow.
1.2 Ratios
BX has a better Return On Assets (5.22%) than 69.30% of its industry peers.
With an excellent Return On Equity value of 31.74%, BX belongs to the best of the industry, outperforming 96.28% of the companies in the same industry.
BX has a Return On Invested Capital of 15.68%. This is amongst the best in the industry. BX outperforms 92.56% of its industry peers.
BX had an Average Return On Invested Capital over the past 3 years of 19.39%. This is significantly above the industry average of 6.96%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.22% | ||
| ROE | 31.74% | ||
| ROIC | 15.68% |
ROA(3y)7.26%
ROA(5y)6.41%
ROE(3y)35.13%
ROE(5y)30.07%
ROIC(3y)19.39%
ROIC(5y)16.24%
1.3 Margins
BX's Profit Margin of 19.46% is in line compared to the rest of the industry. BX outperforms 56.28% of its industry peers.
BX's Profit Margin has declined in the last couple of years.
BX has a better Operating Margin (49.06%) than 82.79% of its industry peers.
BX's Operating Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 49.06% | ||
| PM (TTM) | 19.46% | ||
| GM | N/A |
OM growth 3Y-1.78%
OM growth 5Y-3.22%
PM growth 3Y0.41%
PM growth 5Y-5.14%
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
BX has more shares outstanding than it did 1 year ago.
BX has more shares outstanding than it did 5 years ago.
The debt/assets ratio for BX has been reduced compared to a year ago.
2.2 Solvency
BX has an Altman-Z score of 4.58. This indicates that BX is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 4.58, BX belongs to the best of the industry, outperforming 85.58% of the companies in the same industry.
The Debt to FCF ratio of BX is 2.60, which is a good value as it means it would take BX, 2.60 years of fcf income to pay off all of its debts.
BX has a Debt to FCF ratio of 2.60. This is in the better half of the industry: BX outperforms 78.14% of its industry peers.
BX has a Debt/Equity ratio of 1.53. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of BX (1.53) is worse than 70.23% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.53 | ||
| Debt/FCF | 2.6 | ||
| Altman-Z | 4.58 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
A Current Ratio of 0.67 indicates that BX may have some problems paying its short term obligations.
BX's Current ratio of 0.67 is on the low side compared to the rest of the industry. BX is outperformed by 67.44% of its industry peers.
BX has a Quick Ratio of 0.67. This is a bad value and indicates that BX is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.67, BX is not doing good in the industry: 66.98% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.67 | ||
| Quick Ratio | 0.67 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 3.84% over the past year.
Measured over the past years, BX shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.85% on average per year.
BX shows a strong growth in Revenue. In the last year, the Revenue has grown by 35.42%.
The Revenue has been growing slightly by 3.26% on average over the past years.
EPS 1Y (TTM)3.84%
EPS 3Y14.23%
EPS 5Y10.85%
EPS Q2Q%7.45%
Revenue 1Y (TTM)35.42%
Revenue growth 3Y9.55%
Revenue growth 5Y3.26%
Sales Q2Q%4.83%
3.2 Future
BX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.39% yearly.
Based on estimates for the next years, BX will show a quite strong growth in Revenue. The Revenue will grow by 17.18% on average per year.
EPS Next Y14.03%
EPS Next 2Y23.17%
EPS Next 3Y22.16%
EPS Next 5Y14.39%
Revenue Next Year15.95%
Revenue Next 2Y22.69%
Revenue Next 3Y19.97%
Revenue Next 5Y17.18%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
BX is valuated quite expensively with a Price/Earnings ratio of 47.79.
Based on the Price/Earnings ratio, BX is valued more expensive than 80.47% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 28.96, BX is valued quite expensively.
Based on the Price/Forward Earnings ratio of 32.38, the valuation of BX can be described as expensive.
73.49% of the companies in the same industry are cheaper than BX, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 23.82. BX is valued slightly more expensive when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 47.79 | ||
| Fwd PE | 32.38 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BX is on the same level as its industry peers.
60.47% of the companies in the same industry are cheaper than BX, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 56.91 | ||
| EV/EBITDA | 43.14 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BX does not grow enough to justify the current Price/Earnings ratio.
BX has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as BX's earnings are expected to grow with 22.16% in the coming years.
PEG (NY)3.41
PEG (5Y)4.4
EPS Next 2Y23.17%
EPS Next 3Y22.16%
5. Dividend
5.1 Amount
BX has a Yearly Dividend Yield of 1.90%.
Compared to an average industry Dividend Yield of 9.01, BX is paying slightly less dividend.
BX's Dividend Yield is comparable with the S&P500 average which is at 2.23.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.9% |
5.2 History
The dividend of BX has a limited annual growth rate of 5.34%.
BX has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)5.34%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
196.69% of the earnings are spent on dividend by BX. This is not a sustainable payout ratio.
The dividend of BX is growing, but earnings are growing more, so the dividend growth is sustainable.
DP196.69%
EPS Next 2Y23.17%
EPS Next 3Y22.16%
BLACKSTONE INC
NYSE:BX (11/21/2024, 8:16:39 PM)
Premarket: 194.98 +0.97 (+0.5%)194.01
+8.98 (+4.85%)
Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap235.31B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.9% |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 47.79 | ||
| Fwd PE | 32.38 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)3.41
PEG (5Y)4.4
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.22% | ||
| ROE | 31.74% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 49.06% | ||
| PM (TTM) | 19.46% | ||
| GM | N/A | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.27
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.53 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 0.67 | ||
| Quick Ratio | 0.67 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)3.84%
EPS 3Y14.23%
EPS 5Y
EPS Q2Q%
EPS Next Y14.03%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)35.42%
Revenue growth 3Y9.55%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y